Loading...
Norvasc
Calcium channel blocker • Dihydropyridine CCB
Blocks L-type calcium channels in vascular smooth muscle, causing vasodilation
Drug Class
Calcium channel blocker
Subclass
Dihydropyridine CCB
Half-life
30-50 hours
Time for plasma concentration to decrease by 50%
Protein Binding
93%
Fraction bound to plasma proteins
Therapeutic Index
Wide
Margin between therapeutic and toxic doses